Expectations and Beliefs of Transgender People Regarding Hormonal Treatment

Last updated: July 23, 2022
Sponsor: Central Hospital, Nancy, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05474768
2021PI221
  • Ages 18-80
  • All Genders

Study Summary

Hormonal treatment of gender dysphoria can have repercussions on metabolism, cardiovascular system and fertility and represents à potential oncological risk. According to the recommendations of the Endocrine society. Therefore, initial assessment and follow-up visits are necessary and must be carried out to avoid the apparition of potentially undesirable effects.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • being a parent of adolescent/child presenting Gender dysphoria

  • adult subject (age > 18 years) presenting Gender dysphoria

non-inclusion criteria

  • Severe, uncontrolled psychiatric or somatic illness

  • Chronic alcoholism

  • Substance abuse

  • Refusal or linguistic, physical or psychological incapacity to participate in the study

  • Ongoing pregnancy

Study Design

Total Participants: 20
Study Start date:
February 02, 2022
Estimated Completion Date:
January 31, 2023

Connect with a study center

  • CHRU de Nancy

    Nancy,
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.